Biobeat Technologies will highlight its cuffless blood pressure monitoring innovations during an expert panel at the AHA Hypertension Scientific Sessions, focusing on the shift toward remote ambulatory care.
Biobeat announced its participation in an expert panel at the AHA Hypertension Scientific Sessions, highlighting its cuffless blood pressure monitoring technology.
Biobeat Technologies is set to present its cuffless 24-hour ambulatory blood pressure monitoring technology at the upcoming American Heart Association (AHA) Hypertension Scientific Sessions. The company aims to demonstrate the clinical efficacy and practical integration of its remote monitoring solutions in modern hypertension care.
Biobeat is participating in an expert panel to discuss the clinical evidence and practical application of its cuffless 24-hour ambulatory blood pressure monitoring technology.